Oxford, United Kingdom

Richard Truran

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Oxford Biomedica (UK) Limited. Active years: 2015-2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard Truran: Innovator in Virus Purification

Introduction

Richard Truran is a notable inventor based in Oxford, GB. He has made significant contributions to the field of virus purification, particularly in the development of retroviral and lentiviral vector formulations. With a total of 2 patents, Truran's work has advanced the methodologies used in virology and gene therapy.

Latest Patents

Truran's latest patents focus on a novel process for producing retroviral or lentiviral vector formulations. His innovative approach includes a filter-sterilization step that is not the final step in the purification process. This advancement is crucial for enhancing the efficiency and safety of viral vector production.

Career Highlights

Throughout his career, Richard Truran has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Oxford Biomedica Limited and Oxford Biomedica, Inc. His expertise in virus purification has positioned him as a key player in the development of therapeutic solutions.

Collaborations

Truran has collaborated with esteemed colleagues, including Robert Buckley and Pippa Radcliffe. These partnerships have fostered innovation and contributed to the success of various projects in the field of virology.

Conclusion

Richard Truran's contributions to virus purification and his innovative patents underscore his importance in the biotechnology industry. His work continues to influence advancements in gene therapy and virology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…